Varespladib methyl
Varespladib methyl (LY333013) is an orally bioavailable prodrug of the selective secretory phospholipase A2 (sPLA2) inhibitor Varespladib. It has been utilized in research to investigate sPLA2's role in inflammatory diseases and envenomation, showing activity in both in vitro assays and in vivo animal models.
Product Specifications
CAS Number
172733-08-3
Product Name Alternative
Phospholipase, phospholipase A2 (PLA2), PLA2, Varespladib methyl, LY 333013, LY333013, LY-333013, inhibit, Inhibitor, A002, A-002, A 002
Field of Research
Metabolism Research
Purity
99.42% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (12.68 mM) ; DMSO:95 mg/mL (240.86 mM)
Smiles
C (C (N) =O) (=O) C=1C=2C (N (CC3=CC=CC=C3) C1CC) =CC=CC2OCC (OC) =O
Molecular Formula
C22H22N2O5
Molecular Weight
394.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61712R-PE-Cy7-01 20 µL
MUC5B Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details bsm-61712R-PE-Cy7-02 100 µL
MUC5B Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 